Science and Medicine Group is a market research firm serving the life science, analytical instrument, diagnostic, healthcare, radiology, and dental industries. Founded in 2018, the company supports organizations looking to capitalize on the rapidly evolving intersection of science, medicine, and technology. Through a collection of industry-leading brands, Science and Medicine Group enables companies in analytical instruments, life science, imaging, clinical diagnostic, and dental sectors to thrive in the dynamic market landscape.
The company offers a range of solutions, serving as a strategic partner in developing evidence-based business strategies, creating winning market programs, developing innovative products, digitally engaging the audience, and more. With a focus on market research, Science and Medicine Group delivers tailored solutions, including market analysis reports, industry-specific subscriptions, and custom market research projects.
One of the company's standout offerings is its Amplion platform, providing qualified accounts, relevant decision makers, and timing signals to commercial teams selling to pharma and academic organizations, thereby enhancing lead generation efforts. Noteworthy media brands under the Science and Medicine Group umbrella include AuntMinnie.com, AuntMinnieEurope.com, DrBicuspid.com, LabPulse.com, and The Science Advisory Board, while its market research portfolio includes BioInformatics, IBO, IMV, Kalorama Information, and SDi, with Amplion.com serving as its beacon for market intelligence.
Science and Medicine Group has a track record of serving top Fortune 500 companies globally, offering business intelligence, market research and publications, and marketing platforms to support their growth. With a focus on providing targeted advertising opportunities through engaged digital communities, the company amplifies brands' presence and supports the promotion of products and services to hard-to-reach audiences.
For venture capital firms considering potential investment opportunities, Science and Medicine Group presents a compelling proposition with its unique positioning in the intersection of science, medicine, and technology, its diverse range of solutions and established track record working with top global enterprises in the industry. The company's strategic approach and specialized focus make it an intriguing prospect for investors seeking exposure to the biotechnology and marketing segments.
There is no investment information
No recent news or press coverage available for Science and Medicine Group .